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Abstract
Erythrocyte is one of the earliest and extensively analyzed blood cells in blood 
physiological and clinical studies. The erythrocyte membrane is negatively charged 
and sialic acid residues are responsible for most of the negative charge at the cell 
surface. This negative charge on the red blood cells (RBC) surface is believed to 
prevent RBC aggregation. This charge varies in different disease condition which 
can be determined by zeta potential (ZP) values. The present study deals with 
alteration in zeta potential of erythrocytes in preeclampsia patients. The mean 
erythrocytic ZP of control pregnant women taken during third trimester was found 
to be 21.64 ± 0.3122 mV whereas; when erythrocytic ZP of preeclampsia patients 
was measured it was found to be 15.13 ± 0.1393 mV which was significantly less 
than that of control pregnant volunteers. Alteration in zeta potential value was 
accompanied by endothelial damage which is able to mechanically deform and 
hemolyze erythrocytes as they pass through the capillaries. It was also observed 
from determination of lipid peroxidation of erythrocytes, that there is formation of 
higher concentration of malondialdehyde within the erythrocytes of preeclampsia 
patients. The data suggest that, in preeclampsia there is excessive accumulation of 
oxidative stress which causes injury to vascular endothelial cells by generation of 
lipid peroxides and detachment of sialic acid residues. As a result there is alteration 
in the net negative surface charge on RBCs extracellular membrane which leads to 
alteration in zeta potential value. Thus it can be concluded that zeta potential value 
of erythrocytes can act as a screening test to anticipate pregnancies at high risk for 
this complication.
Keywords: zeta potential, preeclampsia, erythrocytes, sialic acid,  
lipid peroxidation, endothelial damage
1. Introduction
Preeclampsia, first described more than 100 years ago, is a major complica-
tion of pregnancy, and is associated with increased maternal and fetal mortality 
and morbidity [1]. It is a hypertensive disorder of human as well as primate 
pregnancy characterized by a generalized inflammatory state and endothelial 
dysfunction, resulting in disseminated microangiopathic disease with vasospasm 
and hypercoagulation [2]. It occurs in 5–7% of all pregnancies and is a leading 
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cause of maternal and fetal morbidity and mortality [3] together with bleeding 
and infection. Preeclampsia places the mother at risk of convulsions (eclampsia), 
kidney failure, liver failure and death [4]. Clinically, preeclampsia is defined as 
hypertension (blood pressure ≥ 140/90 mmHg) and proteinuria (urinary protein 
≥ 300 mg/24 h). It is also associated with pathological edema, coagulation abnor-
malities and decreased uteroplacental blood flow [5–7]. Despite numerous basic, 
clinical and epidemiologic studies that have been conducted over the past half-
century [8], there is no reliable test to identify women at risk for developing this 
disorder, thus it is important to develop a predictive screening test early in preg-
nancy so that we can anticipate pregnancies at high risk for this complication [9]. 
Recently there is a growing interest in characterizing RBC membrane defects in 
several diseases, as changes in membrane structure contribute to the pathophysiol-
ogy of the disease process [10].
The cell-surface charge is the key biophysical parameter that depends on the 
composition of the cytoplasmic membrane and the physiological condition of 
cells. The general picture of the membrane structure of erythrocyte is that of 
‘Bilayer lipid membrane’ based on the Gorter-Grendel bimolecular leaflet model 
with a thickness of about 100 Å. The N- and C-terminal segments of ‘Glycophorin’, 
the major glycoprotein that spans the RBC membrane may contribute to the 
surface charge. From an electrophoretic point of view, the human erythrocyte 
behaves as a ‘macropolyanion’. The dominant ionogenic species is the carboxyl 
group of N-acetyl neuraminic acid or sialic acid. Other ionic components which 
are involved in charge contribution are the acidic and basic groups of amino acids 
of proteins [11]. When such a charged particle suspended in a liquid is placed in an 
electric field, electrophoresis migrates it towards the oppositely charged electrode 
[12]. This migration is calculated as velocity or mobility of erythrocyte which is 
used to calculate zeta potential.
Zeta potential is an electrochemical property of cell surfaces that is deter-
mined by the net electrical charge of molecules exposed at the surface of cell 
membranes [13]. So long as the zeta potential of the system remains constant, the 
fluidity of the system also remains constant. But if the ZP of the system is lowered 
then the stability of the system undergoes progressive changes [10]. A number of 
reports indicate that blood levels of lipid peroxidation products are elevated in 
women with preeclampsia relative to normal pregnancy [14]. It is also associated 
with oxidative stress and is responsible for the production of reactive oxygen 
species (ROS) which are the contributory factors for vascular endothelial cell 
dysfunctioning [15]. Injury to endothelial cell leads to activation of the clotting 
cascade and promotes platelet aggregation and clot formation [16] which is able to 
mechanically deform and hemolyze erythrocytes as they pass through the capil-
laries [17]. A substantial amount of evidence demonstrates that red cell aggrega-
tion increases in preeclampsia compared with normotensive pregnant women 
[18, 19]. Given the effect of endothelial cell injury and red cell aggregation, the 
purpose of this chapter is to study the effects of the alteration in erythrocytic zeta 
potential in preeclampsia patients as assessed by the cell electrophoresis technique 
using zeta-meter system 4.0.
The following materials are required to study the zeta potential, dextrose 
(Merck), distilled water, lancet, rectified spirit, zeta meter system 4.0. Blood was 
collected from voluntary donors with preeclampsia (n = 88) and control pregnant 
women (n = 60) under treatment in Dalvi memorial hospital and Daga memorial 
hospital, Nagpur. None of the subjects (both control and patients) were addicted to 
any drug/smoking. Each volunteer provided written consent for the study of their 
blood sample.
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2. Preparation of isotonic dextrose solution
A 5% w/v dextrose solution was prepared by dissolving 5 g of anhydrous 
dextrose (Merck) in 100 ml of distilled water.
3. Preparation of blood suspension for zeta potential measurement
Approximately 0.01 ml blood is transferred into 50 ml of freshly prepared 
isotonic dextrose solution. Mean values of the 10 readings are used to calculate the 
zeta potential according to the basic Helmholtz-Smoluchowski equation as follows:
  Zeta potential, ζ =  4π ×  V t × EM ___________
 D t 
 . (1)
where Vt = Viscosity of suspending liquid in poises at temperature ‘t’, 
EM = Electrophoretic mobility at actual temperature, Dt = Dielectric constant, 
ZP = Voltage in electrostatic units.
4.  Estimation of zeta potential of prepared blood sample by zeta meter 
system 4.0
The zeta potential of the RBCs was is measured using zeta meter system 4.0. 
Zeta potential is purely an electro kinetic property of the electrical double layer 
surrounding the system but not the surface of the system itself. The value of zeta 
potential gives an indication about the stability of the system under study. This 
quantity is measured by determining the mobility/velocity of the particle under an 
applied electric field. The value of zeta potential can be obtained from the equation 
given by Helmholtz-Smoluchowski.
  ζ d =  (4πη / ϵ) V (2)
where ζd = electro kinetic potential/zeta potential, η = viscosity of dispersion 
medium, ϵ = dielectric constant of the dispersion medium, V = v/E (mobility of the 
particle), v = velocity of the particle in cm/s, E = potential gradient in V/cm [20].
A special capillary cell called electrophoretic cell is used for the measurement 
of zeta potential. The capillary is embedded inside a chamber having electrodes at 
either of the two ends. Sample is placed from any one end of the electrophoretic 
cell and electrodes are connected to the cell and electric field at specific voltage 
is applied (200 V). Charged particles move towards oppositely charged electrode 
and their velocity is measured and expressed in terms of electro kinetic potential/
zeta potential which indicates the mobility of particle under applied electric field. 
Recently this method is widely used for determining the membrane potential of 
biological membranes.
In this experiment, fresh capillary blood samples were obtained from volun-
teer by puncturing the skin with a lancet and blood suspension was prepared as 
described in above procedure. Prior to zeta potential measurement temperature 
of the RBC suspensions were measured and detection parameters for ZP measure-
ments such as light intensity, focal plane and tracking duration were optimized 
for stable data collection. The RBC suspensions were then added to the previ-
ously cleaned and calibrated (using min-u-sil) zeta-meter cell placed under the 
zeta-meter stage and the mobility of individual RBCs was tracked by equipped 
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Zeta meter-ZM4DAQ software using microscopically-acquired video images, and 
data were recorded 10 times for each sample and average zeta-potential in mv was 
determined using a standard Helmholtz-Smoluchowski formula.
5. Result
The results of blood samples obtained from both patients and control are 
expressed as mean values with standard deviation. Comparison between different 
groups and interpretation of results are based on ‘two-sample t test’ with software 
PRISM 5. Differences between the groups were considered significant at p < 0.05 
which indicates that the control and other patient groups differ significantly from 
one another in all situations. The ZP of erythrocytes was measured by the cell elec-
trophoresis technique using zeta meter system 4.0 at the minimum voltage required 
for the movement of the erythrocytes to travel a fixed distance. In a study con-
ducted in India, Table 1 shows the zeta potential (ZP) values of the erythrocytes 
of control pregnant women in mV while Table 2 shows the zeta potential (ZP) 
values erythrocytes of preeclampsia patients in mV [21] (reference of your work). 
The mean erythrocytic ZP of control pregnant women taken during third trimester 
was found to be 21.64 ± 0.3122 mV whereas; when erythrocytic ZP of preeclampsia 
patients was measured it was found to be 15.13 ± 0.1393 mV. The results as shown 
in Figure 1 revealed that there is a significant decrease in the ZP of the RBC of 
preeclampsia patients as compared with the control pregnant women.
Sr. No. Zeta potential Sr. No. Zeta potential Sr. No. Zeta potential
1 −23.02 (1.95) 22 −26.28 (1.1) 43 −21.36 (1.41)
2 −21.87 (1.4) 23 −24.07 (1.94) 44 −18.13 (1.6)
3 −17.43 (1.33) 24 −19.34 (0.88) 45 −18.46 (1.98)
4 −24.52 (2.6) 25 −16.82 (0.64) 46 −18.11 (1.69)
5 −19.71 (0.77) 26 −19.52 (1.92) 47 −18.04 (0.84)
6 −22.46 (0.92) 27 −19.02 (2.04) 48 −16.38 (0.83)
7 −16.59 (0.64) 28 −19.83 (1.87) 49 −16.41 (2.5)
8 −20.10 (1.39) 29 −21.26 (0.67) 50 −19.88 (1.7)
9 −24.49 (2.36) 30 −19.62 (1.46) 51 −21.15 (1.03)
10 −21.07 (2.28) 31 −20.73 (1.12) 52 −20.52 (0.84)
11 −17.27 (3.59) 32 −20.11 (0.57) 53 −21.02 (2.76)
12 −24.49 (0.93) 33 −25.59 (1.57) 54 −22.68 (1.79)
13 −21.54 (1.71) 34 −20.57 (0.88) 55 −22.50 (1.2)
14 −26.78 (0.99) 35 −25.73 (1.9) 56 −25.21 (2.15)
15 −19.39 (2.47) 36 −21.68 (1.63) 57 −25.11 (2.77)
16 −22.44 (1.12) 37 −21.13 (1.6) 58 −24.19 (2.28)
17 −20.48 (1.62) 38 −19.68 (1.81) 59 −18.43 (0.77)
18 −20.50 (0.83) 39 −19.96 (1.61) 60 −19.34 (2.75)
19 −23.15 (1.54) 40 −20.75 (1.63)
20 −21.06 (1.44) 41 -20.36 (2.43)
21 -21.42 (1.43) 42 -25.65 (1.23)
Table 1. 
Zeta potential of normal pregnant women [21].


















1 −16.00 (1.42) 23 −16.00 
(0.94)
45 −15.62 (0.93) 67 −16.75 (1.62)
2 −13.94 (0.4) 24 −16.16 (0.87) 46 −12.91 (1.58) 68 −14.13 (0.27)
3 −14.45 (0.29) 25 −14.67 (0.8) 47 −15.99 (1.15) 69 −16.5 (1.21)
4 −16.7 (2.1) 26 −15.53 (1.08) 48 −14.94 (0.68) 70 −16.41 (2.5)
5 −14.68 (1.21) 27 −16.74 (2.27) 49 −14.02 (0.35) 71 −15.27 (1.18)
6 −14.00 
(0.71)
28 −16.84 (1.12) 50 −16.58 (0.77) 72 −14.28 (0.57)
7 −16.81 (1.03) 29 −16.53 (1.74) 51 −16.14 (0.57) 73 −13.39 (0.34)
8 −13.44 (0.68) 30 −16.49 (1.12) 52 −15.92 (1.35) 74 −16.07 (0.43)
9 −14.75 (0.4) 31 −14.38 (1.12) 53 −16.68 (1.11) 75 −14.28 (0.4)
10 −15.59 (1.11) 32 −13.71 (0.48) 54 −14.07 (0.73) 76 −13.82 (1.86)
11 −15.51 (1.09) 33 −14.86 (0.85) 55 −14.07 (0.95) 77 −16.71 (1.44)
12 −16.14 (1.52) 34 −16.24 (1.15) 56 −12.13 (0.67) 78 −14.38 (1.12)
13 −12.08 (1.08) 35 −15.24 (1.67) 57 −13.55 (0.62) 79 −14.81 (0.55)
14 −16.59 (0.64) 36 −16.59 (0.89) 58 −16.59 (0.22) 80 −15.32 (0.34)
15 −16.45 (0.73) 37 −14.1 (0.57) 59 −16.89 (0.58) 81 −16.38 (0.83)
16 −14.61 (1.79) 38 −13.86 (1.28) 60 −14.96 (1.26) 82 −13.72 (0.83)
17 −12.12 (0.39) 39 −12.42 (0.83) 61 −16.77 (0.42) 83 −13.72 (2.36)
18 −15.87 (2.1) 40 −13.86 (0.82) 62 −15.28 (0.36) 84 −16.28 (0.94)
19 −15.18 (1.1) 41 −16.92 (1.74) 63 −16.52 (1.32) 85 −12.05 (1.05)
20 −13.72 (0.83) 42 −15.61 (1.08) 64 −15.44 (0.6) 86 −14.65 (0.6)
21 −13.52 (0.48) 43 −13.55 (0.62) 65 −14.81 (1.52) 87 −16.72 (0.46)
22 −16.83 (1.08) 44 −14.67 (0.8) 66 −16.82 (0.64) 88 −13.82 (1.86)
Table 2. 
Zeta potential of preeclampsia patients [21].
Figure 1. 
Comparison of erythrocytic zeta potential of preeclampsia patients and control pregnant women [21].
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6. Discussion
Zeta potential (ZP) is an electrochemical property of cell surfaces that is 
determined by the net electrical charge of molecules exposed at the surface of 
cell membranes. Membrane proteins contribute to the total net electrical charge 
of cell surfaces and can alter ZP through changes in their intermolecular inter-
actions [22]. Erythrocyte is one of the earliest and extensively analyzed blood 
cells in blood physiological and clinical studies [23]. The erythrocyte membrane 
is negatively charged and the major contributor to the negative ZP of RBCs is 
sialic acid, which is abundantly present on the RBC surface [24, 25]. This nega-
tive charge on the RBC surface is believed to prevent RBC aggregation [25]. 
The physiologic changes during normal pregnancy affect red cell aggregation 
[26]. The aggregation properties of the cells depend, in turn, on the shape and 
concentration of red blood cells (RBCs) as well as the presence of sticky pro-
teins [27]. In a cross-sectional study, Ozanne et al. demonstrated that red cells 
aggregation increases during the course of normal pregnancy [28]. Whereas, 
in preeclampsia red blood cell aggregation is further increased when compared 
with normotensive pregnant women; this increase could be due to either the 
changes in fibrinogen system or functional abnormalities of erythrocyte mem-
branes [22]. Andrea et al. observed that erythrocyte aggregation was increased 
in all the hypertensive pregnant patients compared with the normotensive 
pregnant controls, regardless of both the onset (chronic or pregnancy-induced) 
of hypertension and the status of plasma macromolecules. Thus, concluded that 
increased erythrocyte aggregation may be due to either conformational changes 
of the membrane occurring during hypertension or a redistribution of the ionic 
charges on the two surfaces of the membrane [23]. The membrane zeta potential 
and the morphology are the important structural and functional parameters of 
erythrocytes. They affect the deformability and the circulation of erythrocytes 
in a blood vessel. On the other hand, they influence the affinity, aggrega-
tion, metabolism and immunity of the cell [25]. Accordingly, in this study, we 
performed systematic measurements of the membrane zeta potential during 
preeclampsia and comparison was done between blood samples from pregnant 
women as control vs. preeclampsia patients.
7. Conclusion
The zeta potential values of the erythrocytes of pregnant women and pre-
eclampsia patients were determined by cell electrophoresis technique using 
zeta meter system 4.0. Zeta potential (ZP) is a characteristic signature for the 
diagnosis of hemolytic diseases, studies of membrane permeability, and altera-
tions leading to destruction of erythrocytes. To investigate the properties of 
the erythrocyte membrane, we examined the zeta potential measurements for 
the surfaces of erythrocyte of preeclampsia patients during each trimester. The 
electrochemical potential value obtained for preeclampsia patient erythrocytes 
was found to be reduced in comparison with the normal pregnant women 
erythrocyte. Thus it is concluded that increased erythrocyte aggregation may 
be due to either conformational changes of the membrane occurring during 
hypertension or a redistribution of the ionic charges on the two surfaces of 
the membrane and hence reduces the zeta potential of preeclampsia patients’ 
erythrocytes. Measurement of zeta potential is an easy and relatively quick way 
to detect molecular changes that have occurred on the membrane surface of 
erythrocytes.
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